The high prevalence of AS in transforming growth factor beta receptor 2 (TGFBR2) has been recently reported in oral squamous cell carcinoma (OSCC) and in potentially malignant oral disorders (PMDs), with almost no such event detected in normal tissues (Sivadas et al., 2014). Here, TGFBR2 is linked to oral cavity squamous cell carcinoma.